JKS Document Store
 Store FrontAccountSearchProduct ListBasket Contents Checkout 
Search For The Following Word(s):
Sign In

Medicinal Products Lifecycle
Medical Devices
Japan Monitor (ISSN 1550-3429)
Information Meetings
Legislation and Agreements
All in Japan (ISSN 1550-3402)
E-health Japan (ISSN 1550-3410)
EU Pharma & Medical Devices
Free documents

22nd New Drug Evaluation Division Information Meeting (Enterprise-wide Use License)

 
22nd New Drug Evaluation Division Information Meeting (Enterprise-wide Use License)Quantity in Basket:none
Code: JM_I_026
Price:$1,950.00

 
 
 
Quantity:
 
36-page Japan Monitor document. Enterprise-wide Use license. Every year the regulatory and pharmaceutical authorities in Japan are organizing periodic meetings on topics such as new drug approvals (under the title "New Drug Evaluation Division" Information Meeting), ICH, safety and QA of the pharmaceuticals and medical devices. The report on "22nd New Drug Evaluation Division Information Meeting" held in Tokyo on October 19, 2005 is compiled and published by Jouhou Koukai Publishing. For the first time in English the program and the key announcements, formatted, indexed, annotated, hyperlinked and illustrated - 5 figures, over 10 editor's notes, references. Jouhou Koukai Publishing is a Jouhou Koukai business: pharmaceuticals, medical devices, drug approval, regulations, clinical trials, Japan pharmaceutical affairs, and global and Japanese regulatory affairs. Retrieval and consulting on drug approval and technical documents disclosed in Japan. (ISSN 1550-3429) Copyright JKS LLC 2005.


Related Item(s)
Code Name Price    
JM_I_00218th New Drug Evaluation Division Information Meeting (Enterprise-wide Use License) $1,450.00
JM_I_00419th New Drug Evaluation Division Information Meeting (Enterprise-wide Use License) $1,950.00
JM_I_01020th New Drug Evaluation Division Information Meeting (Enterprise-wide Use License) $2,450.00
JM_I_012New Drug Evaluation Division Information Meetings 2004 (Enterprise-wide Use License) $3,500.00
JM_I_01821st New Drug Evaluation Division Information Meeting (Enterprise-wide Use License) $1,950.00
JM_I_022New Drug Evaluation Division Regular Meetings Spring 2004 - Spring 2005 (Enterprise-wide Use License $3,750.00